Feds revoke emergency use of some respirators, mask decontamination in healthcare settings
By
Alicia Lasek
Jul 02, 2021
Healthcare personnel are no longer authorized to use certain respirators not approved by NIOSH or technology for cleaning disposable masks, the FDA says.
Non-surgical face masks are not PPE, feds insist
By
Alicia Lasek
Apr 28, 2020
“Questions and concerns” about a recent emergency use authorization have prompted the FDA to clarify its guidance about face coverings.
Statins not linked to cognitive decline in the elderly
By
Alicia Lasek
Nov 19, 2019
There is no link between statin medications and cognitive decline in older adults, according to a new observational study.
Study shows hip protectors significantly cut fracture risk
By
Alicia Lasek
Jan 05, 2020
Eldercare residents who wore hip protectors reduced their risk of hip fracture nearly threefold, a new study published in the November issue of JAMDA has found.
Hip protectors dramatically reduce injury risk, study finds
By
Alicia Lasek
Nov 22, 2019
The risk of hip fracture was reduced nearly three-fold among elderly care facility residents who wore hip protectors, say researchers.
12-week walking program boosts recall memory in seniors: study
By
Alicia Lasek
May 26, 2023
The story recollection abilities of seniors significantly improved as did brain activity after weeks of supervised walking exercise, investigators say.
Large numbers of Americans with chronic kidney disease have uncontrolled hypertension and diabetes. A national response is needed, researchers say, and a White House initiative may be a start.
Stealth heart attack symptoms often ignored, delaying care
By
Alicia Lasek
Sep 12, 2019
Mild, slow heart attack symptoms may sneak up on residents with multiple health problems, delaying time to treatment by five hours.
‘An apple a day’ may prove strategic defense against frailty, researchers find
By
Alicia Lasek
May 23, 2023
People who consume 10 mg per day of a certain type of flavonoids may lower their risk of developing frailty by 20%, according to new research.
Alzheimer’s drug designed for ‘at-home’ use scores FDA breakthrough designation
By
Alicia Lasek
Oct 12, 2021
The experimental Alzheimer’s drug gantenerumab is the “first and only” anti-amyloid antibody being investigated for subcutaneous administration and could potentially be given to patients...